Page last updated: 2024-08-24

tenofovir and Metabolic Syndrome

tenofovir has been researched along with Metabolic Syndrome in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	4 (66.67)	2.80

Authors

Authors	Studies
Alonso-Castro, AJ; Alvarez-Alvarez, RM; Del Carmen Preciado-Puga, M; Del Rocio Ibarra-Reynoso, L; Lazo-de-la-Vega-Monroy, ML; Ruiz-Noa, Y; Ruiz-Padilla, AJ; Sánchez-Barajas, M	1
Hill, A; Shah, S	2
Ait-Khaled, M; Ajana, F; Jones, B; Nascimento, MC; Santos, J; Scholten, S; Smith, DE; Tenorio, AR; van Wyk, J; Wohlfeiler, M; Wright, J; Wynne, B	1
Ehmer, J; Hatz, C; Hobbins, MA; Labhardt, ND; Motlatsi, MM; Muhairwe, JA; Müller, UF; Muser, J; Pfeiffer, K; Ringera, I	1
Mallal, S; Nolan, D; Reiss, P	1

Reviews

3 review(s) available for tenofovir and Metabolic Syndrome

Article	Year
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy. Current opinion in infectious diseases, 2021, 02-01, Volume: 34, Issue:1 Topics: Alanine; Anti-HIV Agents; Diabetes Mellitus; HIV Infections; HIV Integrase Inhibitors; Humans; Metabolic Syndrome; Tenofovir; Weight Gain	2021
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: Republication. Current opinion in HIV and AIDS, 2021, 03-01, Volume: 16, Issue:2 Topics: Diabetes Mellitus; HIV Infections; HIV Integrase Inhibitors; Humans; Metabolic Syndrome; Tenofovir	2021
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics. Expert opinion on drug safety, 2005, Volume: 4, Issue:2 Topics: Adenine; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kidney Diseases; Lopinavir; Metabolic Syndrome; Nevirapine; Organophosphonates; Oxazines; Pyrimidinones; Risk Factors; Tenofovir	2005

Trials

1 trial(s) available for tenofovir and Metabolic Syndrome

Article	Year
Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study. Journal of acquired immune deficiency syndromes (1999), 2021, 06-01, Volume: 87, Issue:2 Topics: Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Insulin Resistance; Lamivudine; Lipids; Metabolic Syndrome; Oxazines; Piperazines; Pyridones; Tenofovir; Viral Load; Weight Gain	2021

Article

Year

Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.

Journal of acquired immune deficiency syndromes (1999), 2021, 06-01, Volume: 87, Issue:2

Topics: Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Insulin Resistance; Lamivudine; Lipids; Metabolic Syndrome; Oxazines; Piperazines; Pyridones; Tenofovir; Viral Load; Weight Gain

2021

Other Studies

2 other study(ies) available for tenofovir and Metabolic Syndrome

Article	Year
FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment. Current HIV research, 2020, Volume: 18, Issue:5 Topics: Adult; Anti-Retroviral Agents; Atherosclerosis; Female; Fibroblast Growth Factors; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Inflammation; Inflammation Mediators; Lipid Metabolism; Lopinavir; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk Factors; Ritonavir; Tenofovir; Young Adult	2020
Metabolic syndrome in patients on first-line antiretroviral therapy containing zidovudine or tenofovir in rural Lesotho, Southern Africa. Tropical medicine & international health : TM & IH, 2017, Volume: 22, Issue:6 Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Lesotho; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Rural Population; Sex Factors; Tenofovir; Zidovudine	2017

Article

Year

FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment.

Current HIV research, 2020, Volume: 18, Issue:5

Topics: Adult; Anti-Retroviral Agents; Atherosclerosis; Female; Fibroblast Growth Factors; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Inflammation; Inflammation Mediators; Lipid Metabolism; Lopinavir; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk Factors; Ritonavir; Tenofovir; Young Adult

2020

Metabolic syndrome in patients on first-line antiretroviral therapy containing zidovudine or tenofovir in rural Lesotho, Southern Africa.

Tropical medicine & international health : TM & IH, 2017, Volume: 22, Issue:6

Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Lesotho; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Rural Population; Sex Factors; Tenofovir; Zidovudine

2017